Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Advisory

Bicara Therapeutics to Participate in Upcoming March Investor Conferences


Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced that company leadership will participate in two upcoming investor conferences in March:

About Bicara Therapeutics

Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The Company's bifunctional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Bicara's lead product candidate, BCA101, is a first-in-class EGFR/TGF-?-trap bifunctional antibody in clinical development for multiple tumor types. For more information, please visit www.bicara.com or follow us on LinkedIn or X.


These press releases may also interest you

at 18:47
During the second phase of the 135th China Import and Export Fair ("Canton Fair" or "the Fair"), a significant memorandum of cooperation was signed between the Fair and the Guangzhou Branch of the National Archives of Publications and Culture,...

at 17:11
Shanghai Electric (SEHK:2727, SSE:601727) announced that the Company...

at 15:40
Sexton Lawn & Landscapes is thrilled to announce the appointment of Brooks Breland as the leading Lawn and Plant Health Expert. In this role, Breland will...

at 13:05
From April 20 to 21, 2024, China National Silk Museum hosted the seventh annual Chinese Costume Festival, under the theme "Ancient Charm, Modern Style." This event aimed to rejuvenate traditional cultural practices and artifacts, making them resonate...

at 11:00
AngleLock will launch its newest product, Arrow-1, at Automate 2024 in Chicago May 6-9. The 7th Axis Linear Shaft Motor Gantry is the first of its kind, and it's designed for high speed, reliability, and precision motion....

at 10:05
Hikvision has released its full-year 2023 financial results, reporting a total revenue of RMB 89.34 billion, up 7.42% year-over-year. Net profit attributable to shareholders of the company was RMB 14.11 billion, achieving a year-over-year (YoY)...



News published on and distributed by: